Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-24625

Xla Wt + kmt2d MO, Schwenty-Lara J et al. (2019)

Experiment + Assay: Xla Wt + kmt2d MO + NF29/30 (in situ hybridization)
Background: Xla.Outbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
morpholino injection kmt2d MO1 kmt2d (Xla)
 NF stage 3 (4-cell) blastomere
Conditions:
Assay Type Assay Stages Antibody
in situ hybridization NF stage 29 and 30 to NF stage 29 and 30  
Anatomical Phenotypes: abnormal development of primary heart field
Expression Phenotypes (1):
decreased amount tbx20.L expression in primary heart field
Human Disease Associations: congenital heart disease, Kabuki syndrome
Source: Fig. 6 D E F
Article: XB-ART-55860, PubMed